# Fulminant Influenza B Myocarditis in an Adolescent Requiring Venoarterial Extracorporeal Membrane Oxygenation (VA-ECMO): Complete Recovery at a Pediatric Cardiac Referral Center in Mexico

**Authors:** Chantale Gilles-Herrera, Cindy A Hernández-Cárdenas, Alejandra Gutierrez-Lugo, Gabriela I Pereira-Lopez, Claudia González-García, Antonio Benita-Bordes, Oscar Garcia-Sánchez, Antonio Juanico-Enriquez, Juan Calderon-Colmenero

PMC · DOI: 10.7759/cureus.103920 · Cureus · 2026-02-19

## TL;DR

A 13-year-old girl in Mexico recovered fully from severe influenza B-induced heart inflammation after intensive treatment with advanced life support and a team of specialists.

## Contribution

This is the first reported case of fulminant influenza B myocarditis in Mexico with complete recovery using VA-ECMO and multidisciplinary care.

## Key findings

- The patient showed complete cardiac recovery after 45 days of treatment with VA-ECMO and antiviral therapy.
- Multidisciplinary care and early recognition were critical for a favorable outcome in this severe case.
- The case highlights the potential for recovery in pediatric patients with fulminant influenza B myocarditis.

## Abstract

Influenza is a common viral infection associated with seasonal outbreaks; however, fulminant myocarditis secondary to influenza Type B represents a rare and life-threatening complication in the pediatric population, with poorly understood pathophysiology. Only a limited number of cases have been reported worldwide, and to our knowledge, this is the first published case in Mexico. We report the case of a previously healthy 13-year-old girl who presented with a five-day history of nonspecific symptoms and rapidly progressed to cardiogenic shock. Prompt recognition and a multidisciplinary approach were essential, involving the pediatric cardiology, cardiac surgery, intensive care, and cardiac imaging teams. Advanced mechanical circulatory support was initiated, including an intra-aortic balloon pump and extracorporeal membrane oxygenation. Medical management included antiviral therapy, corticosteroids, and intravenous immunoglobulin. Following 45 days of intensive management, the patient demonstrated complete recovery of cardiac function and was discharged with close outpatient follow-up. This case highlights the importance of early recognition of fulminant myocarditis in pediatric patients with influenza infection and demonstrates that timely multidisciplinary management and advanced mechanical circulatory support can result in favorable outcomes, even in severe presentations.

## Linked entities

- **Diseases:** influenza (MONDO:0005812), myocarditis (MONDO:0004496), cardiogenic shock (MONDO:0800175)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Diseases:** viral infection (MESH:D014777), influenza Type B (MESH:D008583), Myocarditis (MESH:D009205), Influenza (MESH:D007251), cardiogenic shock (MESH:D012770)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13005710/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13005710/full.md

## References

27 references — full list in the complete paper: https://tomesphere.com/paper/PMC13005710/full.md

---
Source: https://tomesphere.com/paper/PMC13005710